Block listing Interim Review

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2020 

To:

30 April 2021

Balance of unallotted securities under scheme(s) from previous return:

0

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

300,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

264,481

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

35,519

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2020

To:

30 April 2021

Balance of unallotted securities under scheme(s) from previous return:

1,277,629

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

360,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,255,163

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

382,466

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000